Abstract
BackgroundIntegrated cardiovascular disease (CVD) and HIV (CVD-HIV) care interventions are being adopted to tackle the growing burden of noncommunicable diseases (NCDs) in low-and middle-income countries (LMICs) but there is a paucity of studies on the feasibility of these interventions in LMICs. This scoping review aims to present evidence of the feasibility of integrated CVD-HIV care in LMICs, and the alignment of feasibility reporting in LMICs with the existing implementation science methodology.MethodsA systematic search of published articles including systematic and narrative reviews that reported on integrated CVD-HIV care was conducted, using multiple search engines including PubMed/Medline, Global Health, and Web of Science. We examined the articles for evidence of feasibility reporting. Adopting the definition of Proctor and colleagues (2011), feasibility was defined as the extent to which an intervention was plausible in a given agency or setting. Evidence from the articles was synthesized by level of integration, the chronic care continuum, and stages of intervention development.ResultsTwenty studies, reported in 18 articles and 3 conferences abstracts, reported on feasibility of integrated CVD-HIV care interventions. These studies were conducted in Sub-Saharan Africa, Southeast Asia and South America. Four of these studies were conducted as feasibility studies. Eighty percent of the studies reported feasibility, using descriptive sentences that included words synonymous with feasibility terminologies in existing definition recommended by Proctor and colleagues. There was also an overlap in the use of descriptive phrases for feasibility amongst the selected studies.ConclusionsIntegrating CVD and HIV care is feasible in LMICs, although methodology for reporting feasibility is inconsistent. Assessing feasibility based on settings and integration goals will provide a unique perspective of the implementation landscape in LMICs. There is a need for consistency in measures in order to accurately assess the feasibility of integrated CVD-HIV care in LMICs.
Highlights
Low- and middle-income countries (LMICs) continue to experience a significant double burden of chronic/non-communicable diseases (NCDs) and infectious diseases [1]
Integrating cardiovascular disease (CVD) and HIV care is feasible in low-and middle-income countries (LMICs), methodology for reporting feasibility is inconsistent
Assessing feasibility based on settings and integration goals will provide a unique perspective of the implementation landscape in LMICs
Summary
Low- and middle-income countries (LMICs) continue to experience a significant double burden of chronic/non-communicable diseases (NCDs) and infectious diseases [1]. A prominent integrated model of care is that of cardiovascular diseases (CVD) and HIV/AIDs [1] This model of integrated care was preceded by the aggressive global scale-up of care for HIV, especially in LMICs, which have the highest prevalence of HIV [1]. In line with implementation science frameworks, integrated CVD and HIV (CVD-HIV) evidence-based interventions (EBIs) should strive for maximum reach, efficacy, adoption, implementation, and maintenance, with an eventual goal of translating research into practice [2, 3]. This goal can only be attained if these interventions are feasible, within the settings where they are implemented [4]. This scoping review aims to present evidence of the feasibility of integrated CVD-HIV care in LMICs, and the alignment of feasibility reporting in LMICs with the existing implementation science methodology
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.